Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening

By MedImaging International staff writers
Posted on 12 Jun 2024
Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)
Image: Screening for prostate cancer with first-line MRI is less cost-effective than first-line PSA testing (Photo courtesy of Adobe Stock)

Current prostate cancer (PCa) screening protocols typically begin with prostate-specific antigen (PSA) testing, which, if elevated, may lead to further assessment using multiparametric magnetic resonance imaging (mpMRI). Now, a cost-effectiveness analysis has revealed that using biparametric magnetic resonance imaging (bpMRI) as an initial screening tool is less cost-effective than the traditional approach of first-line PSA testing followed by mpMRI. This conclusion held true even when assuming no cost for bpMRI, indicating that the financial savings do not compensate for the drawbacks of using the first-line MRI approach.

A team of researchers from Fred Hutchinson Cancer Center (Seattle, WA, USA), in collaboration with other institutions, developed a microsimulation model to compare the effectiveness and cost-efficiency of first-line bpMRI versus first-line PSA with reflex mpMRI for prostate cancer screening. The study showed that initiating screening with MRI significantly increased the incidence of false positives, unnecessary prostate biopsies, and overdiagnoses, without a corresponding significant decrease in prostate cancer mortality. The findings suggest that even free bpMRI screening does not offer economic or quality-of-life advantages over the conventional approach of PSA testing followed by mpMRI and, if necessary, MRI-guided prostate biopsy supplemented by transrectal ultrasonography–guided biopsy.

These results underline the importance of focusing screening strategies on minimizing false positives and overdiagnoses to enhance cost-effectiveness. High-quality cost-effectiveness analyses like this are vital for understanding how changes in medical practice impact the broader healthcare system. Moreover, incorporating economic data from such analyses could strengthen the development of guidance statements, as endorsed by the National Comprehensive Cancer Network. It is recommended that other organizations also consider integrating cost-effectiveness information into their guidelines to inform clinical decisions.

Related Links:
Fred Hutchinson Cancer Center

Multi-Use Ultrasound Table
Clinton
Biopsy Software
Affirm® Contrast
Mammography System (Analog)
MAM VENUS
New
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Nuclear Medicine

view channel
Image: Perovskite crystal boules are grown in carefully controlled conditions from the melt (Photo courtesy of Mercouri Kanatzidis/Northwestern University)

New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis

Nuclear medicine scans like single-photon emission computed tomography (SPECT) allow doctors to observe heart function, track blood flow, and detect hidden diseases. However, current detectors are either... Read more

General/Advanced Imaging

view channel
Image: The Angio-CT solution integrates the latest advances in interventional imaging (Photo courtesy of Canon Medical)

Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities

Maintaining accuracy and safety in interventional radiology is a constant challenge, especially as complex procedures require both high precision and efficiency. Traditional setups often involve multiple... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.